adenocarcinomas
aimed
biomarkers
blot
capg
carcinomas
clu
deceased
differently
expressed
expressions
ihc
immunohistochemistry
insufficient
itgb3
localize
microarray
muc5b
none
ovarian
prame
prediction
prognostic
qpcr
semiquantitative
serous
survivors
tacc1
tumors
|